Please use this identifier to cite or link to this item:
http://hdl.handle.net/10637/12435Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?
| Title: | Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS? |
| Authors : | Sanz Santillana, Guillermo F. Ibáñez Company, Mariam Such Taboada, Esperanza |
| Keywords: | Síndromes mielodisplásicos - Aspectos moleculares.; Genes.; Blood cells - Molecular aspects.; Sangre - Células - Aspectos moleculares.; Molecular biology.; Myelodysplastic syndrome - Molecular aspects.; Biología molecular. |
| Publisher: | American Society of Hematology. |
| Citation: | Sanz, G.F., Ibañez, M. & Such, E. (2019). Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?. Blood Advances, vol. 3, i. 21 (12 nov.), pp. 3454–3460. DOI: https://doi.org/10.1182/bloodadvances.2019000680 |
| Description: | Este artículo se encuentra disponible en la siguiente URL: https://ashpublications.org/bloodadvances/article/3/21/3454/422749/Do-next-generation-sequencing-results-drive |
| URI: | http://hdl.handle.net/10637/12435 |
| Rights : | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
| ISSN: | 2473-9529 (Electrónico). |
| Issue Date: | 12-Nov-2019 |
| Center : | Universidad Cardenal Herrera-CEU |
| Appears in Collections: | Dpto. Ciencias Biomédicas |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.